PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Oncology, State Key Laboratory of Translational Oncology, Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Sha Tin, Hong Kong.\', \'Comprehensive Oncology Centre, Hong Kong Sanatorium & Hospital, Happy Valley, Hong Kong.\', \'Division of Urology, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Sha Tin, Hong Kong.\', \'Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong.\', \'Hong Kong Integrated Oncology Centre, Kowloon, Hong Kong.\', \'Asia Clinic, Tsim Sha Tsui, Hong Kong.\', \'Department of Clinical Oncology, Queen Mary Hospital, The University of Hong Kong, Pok Fu Lam, Hong Kong.\', \'Department of Clinical Oncology, Tuen Mun Hospital, Tuen Mun, Hong Kong.\', \'Radiotherapy & Oncology Centre, Hong Kong Baptist Hospital, Kowloon, Hong Kong.\', \'Central Urology Clinic, Central, Hong Kong.\', \'Division of Urology, Department of Surgery, United Christian Hospital, Kowloon, Hong Kong.\', \'Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Pok Fu Lam, Hong Kong.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/ajco.13579
?:doi
?:hasPublicationType
?:journal
  • Asia-Pacific journal of clinical oncology
is ?:pmid of
?:pmid
?:pmid
  • 33860643
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.58
?:rankingScore_hIndex
  • 20
?:title
  • Prostate cancer management in the era of COVID-19: Recommendations from the Hong Kong Urological Association and Hong Kong Society of Uro-oncology.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all